Trademark
Full logoAbout Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company with leading franchises in oncology (Opdivo, Yervoy, Reblozyl), hematology, cardiovascular (Eliquis, in partnership with Pfizer), and immunology. Headquartered in Princeton, New Jersey, the company was formed by the 1989 merger of Bristol-Myers and Squibb and has grown further through major acquisitions including Celgene in 2019 and Karuna Therapeutics and RayzeBio in 2024. The Cobenfy schizophrenia drug from the Karuna deal and a deep pipeline in cell therapy and protein degraders anchor the next chapter of growth. BMS is one of the largest pharmaceutical R&D spenders in the world.
About the Bristol-Myers Squibb logo
The Bristol-Myers Squibb (BMY) logo is part of the Tickericons pack — a hand-crafted set of logos for every company in the S&P 500. Each logo is manually redrawn to a consistent grid, weight, and corner radius so BMY sits cleanly next to other tickers in cap tables, dashboards, equity research, and fintech UI.
You get two styles: the trademark (just the symbol, ideal for grids and tight UI) and the full logo (mark plus wordmark, ideal when there's room to breathe). Both ship as scalable SVG, high-resolution PNG, and reusable Figma components.
Bristol-Myers Squibb was added to the S&P 500 on Mar 4, 1957 and is currently classified under the Health Care sector.
Other Health Care companies
See all →
abtAbbott LaboratoriesMar 4, 195725,302
abbvAbbVieDec 31, 20124,911
aAgilent TechnologiesJun 5, 20009,503
algnAlign TechnologyJun 19, 20173,280
amgnAmgenJan 2, 199212,580
baxBaxter InternationalSep 30, 197219,613
bdxBecton Dickinson and CoSep 30, 197219,613
techBio-Techne CorporationAug 30, 20211,747
biibBiogenNov 13, 20038,247
bsxBoston Scientific CorporationFeb 24, 199511,431
Get all S&P 500 logos
One-time payment. SVG, PNG, and a Figma library. Free updates as the index changes.